Pfizer Inc. and BioNTech mentioned on Thursday they’d requested U.S. regulators to approve emergency use in their COVID-19 vaccine for kids elderly from 5 to 11, Pfizer mentioned in a publish on Twitter.
“We and @BioNTech_Group formally submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in kids five to <12,” the corporate mentioned.
“We’re dedicated to running with the FDA with without equal objective of serving to offer protection to kids in contrast critical public well being risk.”
Pfizer has but to make a complete submission to Well being Canada, however has despatched in preliminary trial knowledge to the Canadian regulator.
The corporate has up to now mentioned it hopes to make a complete submission by means of mid-October.
Pfizer sends preliminary youngsters’ COVID-19 vaccine trial knowledge to Well being Canada
(Reporting by means of Susan Heavey, Modifying by means of Timothy Heritage)
— With recordsdata from International Information.
View hyperlink »